US20070276609A1 - System and method of assessing analgesic adequacy using biopotential variability - Google Patents
System and method of assessing analgesic adequacy using biopotential variability Download PDFInfo
- Publication number
- US20070276609A1 US20070276609A1 US11/731,510 US73151007A US2007276609A1 US 20070276609 A1 US20070276609 A1 US 20070276609A1 US 73151007 A US73151007 A US 73151007A US 2007276609 A1 US2007276609 A1 US 2007276609A1
- Authority
- US
- United States
- Prior art keywords
- subject
- measure
- analgesic
- metric
- adequacy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000000202 analgesic effect Effects 0.000 title claims abstract description 73
- 238000000034 method Methods 0.000 title claims abstract description 36
- 230000000694 effects Effects 0.000 claims abstract description 43
- 210000003205 muscle Anatomy 0.000 claims abstract description 23
- 239000000932 sedative agent Substances 0.000 claims abstract description 23
- 230000001624 sedative effect Effects 0.000 claims abstract description 22
- 230000002980 postoperative effect Effects 0.000 claims description 11
- 239000002831 pharmacologic agent Substances 0.000 claims description 4
- 208000002193 Pain Diseases 0.000 description 54
- 230000036407 pain Effects 0.000 description 53
- 230000004044 response Effects 0.000 description 33
- 230000000392 somatic effect Effects 0.000 description 19
- 206010002091 Anaesthesia Diseases 0.000 description 17
- 230000037005 anaesthesia Effects 0.000 description 17
- 230000036592 analgesia Effects 0.000 description 15
- 230000002490 cerebral effect Effects 0.000 description 15
- 238000012544 monitoring process Methods 0.000 description 12
- 239000000730 antalgic agent Substances 0.000 description 11
- 239000003193 general anesthetic agent Substances 0.000 description 11
- 238000001356 surgical procedure Methods 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 10
- 238000002567 electromyography Methods 0.000 description 10
- 208000004550 Postoperative Pain Diseases 0.000 description 9
- 206010039897 Sedation Diseases 0.000 description 9
- 239000002131 composite material Substances 0.000 description 9
- 230000033001 locomotion Effects 0.000 description 9
- 238000007477 logistic regression Methods 0.000 description 9
- 230000036280 sedation Effects 0.000 description 9
- 230000002596 correlated effect Effects 0.000 description 8
- 206010033799 Paralysis Diseases 0.000 description 7
- 230000003444 anaesthetic effect Effects 0.000 description 7
- 230000000147 hypnotic effect Effects 0.000 description 7
- 238000012423 maintenance Methods 0.000 description 7
- 230000000638 stimulation Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 238000011161 development Methods 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 6
- 229960004134 propofol Drugs 0.000 description 6
- 230000004043 responsiveness Effects 0.000 description 6
- 238000012935 Averaging Methods 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 206010012218 Delirium Diseases 0.000 description 4
- IDBPHNDTYPBSNI-UHFFFAOYSA-N N-(1-(2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)ethyl)-4-(methoxymethyl)-4-piperidyl)propionanilide Chemical compound C1CN(CCN2C(N(CC)N=N2)=O)CCC1(COC)N(C(=O)CC)C1=CC=CC=C1 IDBPHNDTYPBSNI-UHFFFAOYSA-N 0.000 description 4
- 229960001391 alfentanil Drugs 0.000 description 4
- 229940035676 analgesics Drugs 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 210000001508 eye Anatomy 0.000 description 4
- 230000000004 hemodynamic effect Effects 0.000 description 4
- 229940005483 opioid analgesics Drugs 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 229940125723 sedative agent Drugs 0.000 description 4
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 3
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 3
- 241001535291 Analges Species 0.000 description 3
- 206010061991 Grimacing Diseases 0.000 description 3
- ZTVQQQVZCWLTDF-UHFFFAOYSA-N Remifentanil Chemical compound C1CN(CCC(=O)OC)CCC1(C(=O)OC)N(C(=O)CC)C1=CC=CC=C1 ZTVQQQVZCWLTDF-UHFFFAOYSA-N 0.000 description 3
- 230000037007 arousal Effects 0.000 description 3
- 230000002146 bilateral effect Effects 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000003983 inhalation anesthetic agent Substances 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 239000000842 neuromuscular blocking agent Substances 0.000 description 3
- 229960003394 remifentanil Drugs 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 210000003813 thumb Anatomy 0.000 description 3
- 206010021576 Inadequate analgesia Diseases 0.000 description 2
- 206010028347 Muscle twitching Diseases 0.000 description 2
- 208000026301 Postoperative Cognitive Complications Diseases 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 229940035674 anesthetics Drugs 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002939 deleterious effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 231100000673 dose–response relationship Toxicity 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000004886 head movement Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001769 paralizing effect Effects 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000003672 processing method Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 238000002627 tracheal intubation Methods 0.000 description 2
- 239000003039 volatile agent Substances 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010020100 Hip fracture Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 1
- 208000000114 Pain Threshold Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002283 elective surgery Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000004424 eye movement Effects 0.000 description 1
- 230000000193 eyeblink Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 238000002682 general surgery Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229960002725 isoflurane Drugs 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000037023 motor activity Effects 0.000 description 1
- 238000003062 neural network model Methods 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 229960001730 nitrous oxide Drugs 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 239000000014 opioid analgesic Substances 0.000 description 1
- 229940124636 opioid drug Drugs 0.000 description 1
- 238000012141 orotracheal intubation Methods 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000037040 pain threshold Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4821—Determining level or depth of anaesthesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/369—Electroencephalography [EEG]
- A61B5/372—Analysis of electroencephalograms
- A61B5/374—Detecting the frequency distribution of signals, e.g. detecting delta, theta, alpha, beta or gamma waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/389—Electromyography [EMG]
- A61B5/397—Analysis of electromyograms
Definitions
- the anesthetic administration is complicated by the multiple effects of the administered anesthetic agents.
- volatile agents have analgesic as well as sedative effects
- an increase in the administered concentration of a volatile agent will result in a concomitant, and possibly undesired, increase in analgesic effect.
- All anesthetic agents have deleterious effects associated with excessive doses. While the effect on the patient may be estimated from the administered dose, patients vary widely in their response to a specific dose and such estimates are therefore based upon group norms (average effects). While the group norm may be representative of the effect of a specific dose on a population of patients, the actual effect in any one patient may vary widely.
- the CVM Index In order to reduce the variation of the trended (time series) of the CVM Index, the change from sample to sample, it may be desirable to smooth the CVM Index. This may be accomplished by averaging some number of the most recent CVM Index values, with larger number of values being averaged together to provide a smoother and slower response, or fewer number of values being averaged together to provide a more variable and faster response. Such averaging may be equally weighted or weighted in a manner in which the influence of each CVM Index value in the average varies depending upon some weighting function.
- An example of such a weighting function is an inverse age function, in which the individual CVM Index values are weighted (multiplied) by the inverse of there age. This technique has the effect of weighting the most recent CVM Index values more strongly than older ones.
- smoothing is not applied, since the temporal averaging inherent in the calculation of BIS and EMG provides adequate smoothing.
- the consciousness monitors manufactured by Aspect Medical Systems generate a variable called Suppression Ratio (SR) which quantifies the degree to which the EEG waveform is suppressed.
- SR Suppression Ratio
- the preferred embodiment of the invention does not calculate a value for the CVM Index when the value of SR rises above a threshold, preferably 40.
- FIG. 4 The analysis of the pain scores ranked by quintiles is shown in FIG. 4 .
- Graph A in FIG. 4 shows a rank-ordered increase in the SD of BIS with increased pain score. The increase of SD of BIS is consistent across the range of pain scores.
- Graph B in FIG. 4 shows the relationship between the SD of EMG and pain score. While there is essentially no difference in the SD of EMG at the two lowest pain scores (1 and 2), there is a rapid rank-ordered increase with pain scores 3-5.
- Graph C in FIG. 4 shows the relationship of the CVM Index to postoperative the pain score. The combination of the SD of both BIS and EMG in the CVM Index results in a consistent rank-ordered increase across pain scores.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/731,510 US20070276609A1 (en) | 2006-03-31 | 2007-03-30 | System and method of assessing analgesic adequacy using biopotential variability |
US13/159,459 US8538705B2 (en) | 2006-03-31 | 2011-06-14 | System and method of assessing analgesic adequacy using biopotential variability |
US14/020,740 US20140012153A1 (en) | 2006-03-31 | 2013-09-06 | System and method of assessing analgesic adequacy using biopotential variability |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78799206P | 2006-03-31 | 2006-03-31 | |
US11/731,510 US20070276609A1 (en) | 2006-03-31 | 2007-03-30 | System and method of assessing analgesic adequacy using biopotential variability |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/159,459 Continuation US8538705B2 (en) | 2006-03-31 | 2011-06-14 | System and method of assessing analgesic adequacy using biopotential variability |
Publications (1)
Publication Number | Publication Date |
---|---|
US20070276609A1 true US20070276609A1 (en) | 2007-11-29 |
Family
ID=38564266
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/731,510 Abandoned US20070276609A1 (en) | 2006-03-31 | 2007-03-30 | System and method of assessing analgesic adequacy using biopotential variability |
US13/159,459 Active 2027-04-14 US8538705B2 (en) | 2006-03-31 | 2011-06-14 | System and method of assessing analgesic adequacy using biopotential variability |
US14/020,740 Abandoned US20140012153A1 (en) | 2006-03-31 | 2013-09-06 | System and method of assessing analgesic adequacy using biopotential variability |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/159,459 Active 2027-04-14 US8538705B2 (en) | 2006-03-31 | 2011-06-14 | System and method of assessing analgesic adequacy using biopotential variability |
US14/020,740 Abandoned US20140012153A1 (en) | 2006-03-31 | 2013-09-06 | System and method of assessing analgesic adequacy using biopotential variability |
Country Status (9)
Country | Link |
---|---|
US (3) | US20070276609A1 (ja) |
EP (1) | EP2007279B1 (ja) |
JP (1) | JP5108870B2 (ja) |
CN (1) | CN101426422A (ja) |
AU (1) | AU2007233071B2 (ja) |
BR (1) | BRPI0710104A2 (ja) |
CA (1) | CA2647729A1 (ja) |
MX (1) | MX2008012591A (ja) |
WO (1) | WO2007115215A2 (ja) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080249431A1 (en) * | 2006-09-29 | 2008-10-09 | The Regents Of The University Of California | Burst suppression monitor for induced coma |
US20080249430A1 (en) * | 2007-04-05 | 2008-10-09 | Erwin Roy John | System and Method for Pain Detection and Computation of a Pain Quantification Index |
US20110295196A1 (en) * | 2009-01-15 | 2011-12-01 | Hopital Foch | System for controlling means for injection of anesthetics or sedatives |
US8731652B2 (en) | 2008-03-17 | 2014-05-20 | Med Storm Innovation As | Method and apparatus for monitoring the autonomous nervous system of a sedated patient |
US10537677B2 (en) | 2009-01-15 | 2020-01-21 | Medsteer | System for controlling injectors of anaesthetics or sedatives with a view to inducing anaesthesia or sedation |
US11273283B2 (en) | 2017-12-31 | 2022-03-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11317858B2 (en) * | 2016-09-05 | 2022-05-03 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Medical monitoring device and method and system for displaying patient monitoring information |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
US11452839B2 (en) | 2018-09-14 | 2022-09-27 | Neuroenhancement Lab, LLC | System and method of improving sleep |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
US11723579B2 (en) | 2017-09-19 | 2023-08-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0622512D0 (en) * | 2006-11-13 | 2006-12-20 | Wenman Alan | Depth of anaesthesia and analgesia |
JP2009261779A (ja) * | 2008-04-28 | 2009-11-12 | Univ Of Electro-Communications | 痛み評価方法及び痛み評価装置 |
US9326725B2 (en) | 2010-03-30 | 2016-05-03 | Children's National Medical Center | Apparatus and method for human algometry |
EP2621333B1 (en) | 2010-09-28 | 2015-07-29 | Masimo Corporation | Depth of consciousness monitor including oximeter |
US20140303453A1 (en) * | 2011-07-06 | 2014-10-09 | Ontario Hospital Research Institute | System and Method for Generating Composite Measures of Variability |
CN103169466B (zh) * | 2013-04-01 | 2015-07-22 | 张宇奇 | 一种用于麻醉的痛觉监护系统及监护方法 |
US9849241B2 (en) | 2013-04-24 | 2017-12-26 | Fresenius Kabi Deutschland Gmbh | Method of operating a control device for controlling an infusion device |
EP2799009A1 (en) * | 2013-04-29 | 2014-11-05 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Non-invasive method for prediction of opioid-analgesia and opioid-blood-concentrations |
US9239619B2 (en) * | 2013-11-08 | 2016-01-19 | Applied Invention, Llc | Use of light transmission through tissue to detect force |
US9955894B2 (en) | 2014-01-28 | 2018-05-01 | Covidien Lp | Non-stationary feature relationship parameters for awareness monitoring |
WO2016057553A1 (en) | 2014-10-07 | 2016-04-14 | Masimo Corporation | Modular physiological sensors |
US10835144B2 (en) * | 2014-10-22 | 2020-11-17 | Ekg Technology Lab, Inc. | Electroencephalograph, brain wave measurement method, brain wave measurement system |
EP3232917B1 (en) * | 2014-12-18 | 2019-09-18 | Quantium Medical S.L. | Apparatus for the assessment of the level of pain and nociception during general anesthesia using electroencephalogram, plethysmographic impedance cardiography, heart rate variability and the concentration or biophase of the analgesics |
CN106200975B (zh) * | 2016-07-15 | 2019-06-21 | 广州视源电子科技股份有限公司 | 一种生物反馈放松方法及装置 |
CN115279258A (zh) * | 2020-01-16 | 2022-11-01 | 布洛里拉私人有限公司 | 用于检测和分类从eeg记录中获得的信号段的方法和系统 |
CN112244870B (zh) * | 2020-09-24 | 2022-02-22 | 杭州电子科技大学 | 基于符号化排列传递熵的癫痫脑电双向耦合分析方法 |
CN113499035B (zh) * | 2021-07-12 | 2023-09-05 | 扬州大学 | 一种基于置信区间融合阈值判据的疼痛识别系统 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6934579B2 (en) * | 1996-09-11 | 2005-08-23 | The University Court Of The University Of Glasgow | Anaesthesia control system |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5010891A (en) * | 1987-10-09 | 1991-04-30 | Biometrak Corporation | Cerebral biopotential analysis system and method |
JPH03136408A (ja) | 1989-10-23 | 1991-06-11 | Fujitsu Ten Ltd | 音質制御装置 |
US5458117A (en) * | 1991-10-25 | 1995-10-17 | Aspect Medical Systems, Inc. | Cerebral biopotential analysis system and method |
US5601090A (en) | 1994-07-12 | 1997-02-11 | Brain Functions Laboratory, Inc. | Method and apparatus for automatically determining somatic state |
US6117075A (en) | 1998-09-21 | 2000-09-12 | Meduck Ltd. | Depth of anesthesia monitor |
US6757558B2 (en) | 2000-07-06 | 2004-06-29 | Algodyne, Ltd. | Objective pain measurement system and method |
US6801803B2 (en) | 2000-10-16 | 2004-10-05 | Instrumentarium Corp. | Method and apparatus for determining the cerebral state of a patient with fast response |
US6731975B1 (en) | 2000-10-16 | 2004-05-04 | Instrumentarium Corp. | Method and apparatus for determining the cerebral state of a patient with fast response |
US20040015091A1 (en) | 2002-04-01 | 2004-01-22 | Aspect Medical Systems | System and method of assessment of arousal, pain and stress during anesthesia and sedation |
JP2006514570A (ja) | 2003-05-06 | 2006-05-11 | エヴェレスト バイオメディカル インストルメンツ | 麻酔および鎮静監視のシステムおよび方法 |
US7367949B2 (en) | 2003-07-07 | 2008-05-06 | Instrumentarium Corp. | Method and apparatus based on combination of physiological parameters for assessment of analgesia during anesthesia or sedation |
US7215994B2 (en) * | 2004-02-17 | 2007-05-08 | Instrumentarium Corporation | Monitoring the neurological state of a patient |
US7447541B2 (en) * | 2004-06-30 | 2008-11-04 | Instrumentarium Corporation | Monitoring subcortical responsiveness of a patient |
US7925338B2 (en) | 2005-03-24 | 2011-04-12 | General Electric Company | Determination of the anesthetic state of a patient |
US20070167694A1 (en) | 2005-12-21 | 2007-07-19 | Everest Biomedical Instruments Co. | Integrated Portable Anesthesia and Sedation Monitoring Apparatus |
-
2007
- 2007-03-30 EP EP07759890.2A patent/EP2007279B1/en not_active Not-in-force
- 2007-03-30 WO PCT/US2007/065708 patent/WO2007115215A2/en active Application Filing
- 2007-03-30 CA CA002647729A patent/CA2647729A1/en not_active Abandoned
- 2007-03-30 MX MX2008012591A patent/MX2008012591A/es unknown
- 2007-03-30 JP JP2009503320A patent/JP5108870B2/ja not_active Expired - Fee Related
- 2007-03-30 BR BRPI0710104-0A patent/BRPI0710104A2/pt not_active Application Discontinuation
- 2007-03-30 US US11/731,510 patent/US20070276609A1/en not_active Abandoned
- 2007-03-30 CN CNA200780012029XA patent/CN101426422A/zh active Pending
- 2007-03-30 AU AU2007233071A patent/AU2007233071B2/en not_active Ceased
-
2011
- 2011-06-14 US US13/159,459 patent/US8538705B2/en active Active
-
2013
- 2013-09-06 US US14/020,740 patent/US20140012153A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6934579B2 (en) * | 1996-09-11 | 2005-08-23 | The University Court Of The University Of Glasgow | Anaesthesia control system |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080249431A1 (en) * | 2006-09-29 | 2008-10-09 | The Regents Of The University Of California | Burst suppression monitor for induced coma |
US8649855B2 (en) * | 2006-09-29 | 2014-02-11 | The Regents Of The University Of California | Burst suppression monitor for induced coma |
US9597006B2 (en) | 2006-09-29 | 2017-03-21 | The Regents Of The University Of California | Burst suppression monitor for induced coma |
US9402558B2 (en) * | 2007-04-05 | 2016-08-02 | New York University | System and method for pain detection and computation of a pain quantification index |
US20080249430A1 (en) * | 2007-04-05 | 2008-10-09 | Erwin Roy John | System and Method for Pain Detection and Computation of a Pain Quantification Index |
US8731652B2 (en) | 2008-03-17 | 2014-05-20 | Med Storm Innovation As | Method and apparatus for monitoring the autonomous nervous system of a sedated patient |
US10537677B2 (en) | 2009-01-15 | 2020-01-21 | Medsteer | System for controlling injectors of anaesthetics or sedatives with a view to inducing anaesthesia or sedation |
US8864702B2 (en) * | 2009-01-15 | 2014-10-21 | Hopital Foch | System for controlling means for injection of anesthetics or sedatives |
US20110295196A1 (en) * | 2009-01-15 | 2011-12-01 | Hopital Foch | System for controlling means for injection of anesthetics or sedatives |
US11317858B2 (en) * | 2016-09-05 | 2022-05-03 | Shenzhen Mindray Bio-Medical Electronics Co., Ltd. | Medical monitoring device and method and system for displaying patient monitoring information |
US11723579B2 (en) | 2017-09-19 | 2023-08-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement |
US11717686B2 (en) | 2017-12-04 | 2023-08-08 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to facilitate learning and performance |
US11273283B2 (en) | 2017-12-31 | 2022-03-15 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11318277B2 (en) | 2017-12-31 | 2022-05-03 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11478603B2 (en) | 2017-12-31 | 2022-10-25 | Neuroenhancement Lab, LLC | Method and apparatus for neuroenhancement to enhance emotional response |
US11364361B2 (en) | 2018-04-20 | 2022-06-21 | Neuroenhancement Lab, LLC | System and method for inducing sleep by transplanting mental states |
US11452839B2 (en) | 2018-09-14 | 2022-09-27 | Neuroenhancement Lab, LLC | System and method of improving sleep |
US11786694B2 (en) | 2019-05-24 | 2023-10-17 | NeuroLight, Inc. | Device, method, and app for facilitating sleep |
Also Published As
Publication number | Publication date |
---|---|
EP2007279A2 (en) | 2008-12-31 |
EP2007279A4 (en) | 2011-10-19 |
US20140012153A1 (en) | 2014-01-09 |
AU2007233071A1 (en) | 2007-10-11 |
WO2007115215A3 (en) | 2008-04-24 |
US8538705B2 (en) | 2013-09-17 |
MX2008012591A (es) | 2008-10-10 |
WO2007115215A2 (en) | 2007-10-11 |
US20110245709A1 (en) | 2011-10-06 |
JP5108870B2 (ja) | 2012-12-26 |
JP2009532130A (ja) | 2009-09-10 |
CN101426422A (zh) | 2009-05-06 |
CA2647729A1 (en) | 2007-10-11 |
AU2007233071B2 (en) | 2013-09-26 |
BRPI0710104A2 (pt) | 2011-08-02 |
EP2007279B1 (en) | 2015-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8538705B2 (en) | System and method of assessing analgesic adequacy using biopotential variability | |
Kane et al. | A revised glossary of terms most commonly used by clinical electroencephalographers and updated proposal for the report format of the EEG findings. Revision 2017 | |
US6801803B2 (en) | Method and apparatus for determining the cerebral state of a patient with fast response | |
US7228169B2 (en) | Method and apparatus for determining the cerebral state of a patient with fast response | |
EP1495715B1 (en) | A method and apparatus based on combination of three phsysiological parameters for assessment of analgesia during anesthesia or sedation | |
EP1757226B1 (en) | Measurement of responsiveness of a patient under anaesthesia | |
EP1665981A1 (en) | Identification of a dominant signal component in a biosignal | |
CN107530023B (zh) | 用于脑电图检查的装置和方法 | |
Pomfrett et al. | Respiratory sinus arrhythmia: an index of light anaesthesia | |
Sinha et al. | Monitoring devices for measuring the depth of anaesthesia–An overview | |
WO2014091291A1 (en) | A device and method for determining the probability of response to pain and nociception of a subject t | |
Rabbani et al. | Estimation the depth of anesthesia by the use of artificial neural network | |
Telser et al. | Temporally resolved fluctuation analysis of sleep ECG | |
Kennedy et al. | Monitoring techniques: neuromuscular blockade and depth of anaesthesia | |
Agarwal et al. | Monitoring the depth of anaesthesia | |
Kangas et al. | Neurometric assessment of adequacy of intraoperative anesthetic | |
EP1859733A1 (de) | Verfahren und Vorrichtung zur Korrelation von Signalen der Atmung des Herz-Kreislauf-Systems | |
Imhoff | Correlation between the EEG monitors BIS and State entropy and their performance in differentiate consciousness and unconsciousness-an EEG Reanalysis | |
Ryser | Movement-based sleep detection–a wearable sensor system to assess quantity and quality of sleep | |
Nguyen-Ky | Monitoring the depth of anaesthesia using simplified electroencephalogram (EEG) | |
Melia et al. | Signal Analysis and Response Measurement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ASPECT MEDICAL SYSTEMS, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GREENWALD, SCOTT D.;REEL/FRAME:019648/0934 Effective date: 20070730 |
|
AS | Assignment |
Owner name: ASPECT MEDICAL SYSTEMS, LLC, MASSACHUSETTS Free format text: MERGER;ASSIGNOR:ASPECT MEDICAL SYSTEMS, INC.;REEL/FRAME:023758/0188 Effective date: 20091223 Owner name: NELLCOR PURITAN BENNETT LLC, MISSOURI Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ASPECT MEDICAL SYSTEMS, LLC;REEL/FRAME:023761/0707 Effective date: 20091225 Owner name: ASPECT MEDICAL SYSTEMS, LLC,MASSACHUSETTS Free format text: MERGER;ASSIGNOR:ASPECT MEDICAL SYSTEMS, INC.;REEL/FRAME:023758/0188 Effective date: 20091223 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |